Renin angiotensin system modulates mTOR pathway through AT2R in HIVAN

Experimental and Molecular Pathology

Volumn 96, Issue 3, 2014, Pages 431-437

  Rai, Partab ^a   Lederman, Rivka ^a   Haque, Shabirul ^a   Rehman, Shabina ^a   Kumar, Viki ^a   Sataranatrajan, Kavithalakshmi ^b   Malhotra, Ashwani ^a   Kasinath, Balakuntalam S ^b   Singhal, Pravin C ^a  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Angiotensin II type 1 receptor; Angiotensin II type II receptor; Renal proximal tubular cells; Renin

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ALISKIREN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ELONGATION FACTOR 2; LOSARTAN; MAMMALIAN TARGET OF RAPAMYCIN; RENIN; S6 KINASE; TRANSCRIPTION FACTOR E2F1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HIV ASSOCIATED NEPHROPATHY; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; KIDNEY TUBULE CELL; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; REGULATOR GENE; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

ANGIOTENSIN II TYPE 1 RECEPTOR; ANGIOTENSIN II TYPE II RECEPTOR; RENAL PROXIMAL TUBULAR CELLS; RENIN;

AIDS-ASSOCIATED NEPHROPATHY; AMIDES; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; FUMARATES; HIV; KIDNEY DISEASES; LOSARTAN; MICE; MICE, TRANSGENIC; PHOSPHORYLATION; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84899786977     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.04.004     Document Type: Article

References (38)

1. Armando I., Jezova M., Juorio A.V., Terron J.A., Falcon-Neri A., Semino-Mora C., et al. Estrogen upregulates renal angiotensin II AT(2) receptors. Am. J. Physiol. Renal Physiol. 2002, 283:F934-F943.
2. Atta M.G. Diagnosis and natural history of HIV-associated nephropathy. Adv. Chronic Kidney Dis. 2010, 17:52-58.
3. Baiardi G., Macova M., Armando I., Ando H., Tyurmin D., Saavedra J.M. Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat. Regul. Pept. 2005, 124:7-17.
4. Barisoni L., Kriz W., Mundel P., D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J. Am. Soc. Nephrol. 1999, 10:51-56.
5. Bautista R., Sanchez A., Hernandez J., Oyekan A., Escalante B. Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure. Hypertension 2001, 38:669-673.
6. Bird J.E., Durham S.K., Giancarli M.R., Gitliz P.H., Pandya D.G., Dambach D.M., Mozes M.M., Kopp B. Captopril prevents nephropathy in HIV-transgenic mice. J. Am. Soc. Nephrol. 1989, 9:1441-1447.
7. Burks T.N., Andres-Mateos E., Marx R., Mejias R., Van Erp C., Simmers J.L., Walston J.D., Ward C.W., Cohn R.D. Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci. Transl. Med. 2011, 3:82.
8. Burns C., Paul S.K., Toth I.R., Siva L. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J. Am. Soc. Nephrol. 1999, 8:1140-1146.
9. Cao Z., Kelly D.J., Cox A., Casley D., Forbes J.M., Martinello P., et al. Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. Kidney Int. 2000, 58:2437-2451.
10. Cao Z., Bonnet F., Candido R., Nesteroff S.P., Burns W.C., Kawachi H., et al. Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J. Am. Soc. Nephrol. 2002, 13:1773-1787.
11. Chandel N., Sharma B., Husain M., Salhan D., Singh T., Rai P., Mathieson P.W., Saleem M.A., Malhotra A., Singhal P.C. HIV compromises integrity of the podocyte actin cytoskeleton through downregulation of the vitamin D receptor. Am. J. Physiol. Renal Physiol. 2013, 304:F1347-F1357.
12. Ciuffo G.M., Viswanathan M., Seltzer A.M., Tsutsumi K., Saavedra J.M. Glomerular angiotensin II receptor subtypes during development of rat kidney. Am. J. Physiol. 1993, 265:F264-F271.
13. Day R.T., Cavaglieri Rde C., Tabatabaimir H., Mantravadi V., Lee M.J., Barnes J.L., Kasinath B.S., Feliers D. Acute hyperglycemia rapidly stimulates VEGF mRNA translation in the kidney. Role of angiotensin type 2 receptor (AT2). Cell. Signal. 2010, 22:1849-1857.
14. de P Rodrigues S.F., dos Santos R.A., Silva-Antonialli M.M., Scavone C., Nigro D., Carvalho M.H., et al. Differential effect of losartan in female and male spontaneously hypertensive rats. Life Sci. 2006, 78:2280-2285.
15. Diniz G.P., Carneiro-Ramos M.S., Barreto-Chaves M.L. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway. Basic Res. Cardiol. 2009, 104:653-667.
16. Griendling K.K., Lassegue B., Alexander R.W. Angiotensin receptors and their therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 1996, 36:281-306.
17. Hashimoto N., Maeshima Y., Satoh M., Odawara M., Sugiyama H., Kashihara N., et al. Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am. J. Physiol. Renal Physiol. 2004, 286:F516-F525.
18. Ideura H., Hiromura K., Hiramatsu N., Shigehara T., Takeuchi S., Tomioka M., Sakairi T., Yamashita S., Maeshima A., Kaneko Y., Kuroiwa T., Kopp J.B., Nojima Y. Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy. Am. J. Physiol. Renal Physiol. 2007, 293:F1214-F1221.
19. Kimmel P.L., Barisoni L., Kopp J.B. Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann. Intern. Med. 2003, 139:214-226.
20. Kumar D., Konkimalla S., Yadav A., Sataranatarajan K., Kasinath B.S., Chander P.N. Singhal PC.HIV-associated nephropathy: role of mammalian target of rapamycin pathway. Am. J. Pathol. 2010, 177:813-821.
21. Kumar D., Salhan D., Magoon S., Torri D.D., Sayeneni S., Sagar A., Bandhlish A., Malhotra A., Chander P.N., Singhal P.C. Adverse host factors exacerbate occult HIV-associated nephropathy. Am. J. Pathol. 2011, 179:1681-1692.
22. Kumar D., Plagov A., Yadav I., Torri D.D., Sayeneni S., Sagar A., Rai P., Adabala M., Lederman R., Chandel N., Ding G., Malhotra A., Singhal P.C. Inhibition of renin activity slows down the progression of HIVAN. Am. J. Physiol. Renal Physiol. 2012, 303:F711-F720.
23. Mavroeidi V., Petrakis I., Stylianou K., Katsarou T., Giannakakis K., Perakis K., Vardaki E., Stratigis S., Ganotakis E., Papavasiliou S., Daphnis E. Losartan affects glomerular AKT and mTOR phosphorylation in an experimental model of type 1 diabetic nephropathy. J. Histochem. Cytochem. 2013, 61:433-443.
24. Mezzano S.A., Ruiz-Ortega M., Egido J. Angiotensin II and renal fibrosis. Hypertension 2001, 38:635-638.
25. Ozono R., Wang Z.Q., Moore A.F., Inagami T., Siragy H.M., Carey R.M. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 1947, 30:1238-1246.
26. Rai P., Plagov A., Lan X., Chandel N., Singh T., Lederman R., Ayasolla K.R., Mathieson P.W., Saleem M.A., Husain M., Malhotra A., Chander P.N., Singhal P.C. mTOR plays a critical role in p53-induced oxidative kidney cell injury in HIVAN. Am. J. Physiol. Renal Physiol. 2013, 305:F343-F354.
27. Rehman S., Husain M., Yadav A., Kasinath B.S., Malhotra A., Singhal P.C. HIV-1 promotes renal tubular epithelial cell protein synthesis: role of mTOR pathway. PLoS One 2012, 7:e30071.
28. Ruiz-Ortega M., Esteban V., Suzuki Y., Ruperez M., Mezzano S., Ardiles L., et al. Renal expression of angiotensin type 2 (AT2) receptors during kidney damage. Kidney Int. 2003, (Suppl.):S21-S26.
29. Salhan D., Sagar A., Kumar D., Rattanavich R., Rai P., Maheshwari S., Adabala M., Husain M., Ding G., Malhotra A., Chander P.N. Singhal PC.HIV-associated nephropathy: role of AT2R. Cell. Signal. 2012, 24:734-741.
30. Salhan D., Husain M., Subrati A., Goyal R., Singh T., Rai P., Malhotra A., Singhal P.C. HIV-induced kidney cell injury: role of ROS-induced downregulated vitamin D receptor. Am. J. Physiol. Renal Physiol. 2012, 303:F503-F514.
31. Shanmugam C., Llorens-Cortes C., Clauser E., Corvol P., Gasc J.M. Expression of angiotensin II AT2 receptor mRNA during development of rat kidney and adrenal gland. Am. J. Physiol. 1995, 268:F922-F930.
32. Tejera N., Gomez-Garre D., Lazaro A., Gallego-Delgado J., Alonso C., Blanco J., et al. Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells. Am. J. Pathol. 2004, 164:1817-1826.
33. Timmermans P.B., Wong P.C., Chiu A.T., Herblin W.F., Benfield P., Carini D.J., et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 1993, 45:205-251.
34. Vazquez E., Coronel I., Bautista R., Romo E., Villalon C.M., Avila-Casado M.C., et al. Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation. Am. J. Physiol. Renal Physiol. 2005, 288:F207-F213.
35. Whaley-Connell A., Habibi J., Panfili Z., Hayden M.R., Bagree S., Nistala R., Hyder S., Krueger B., Demarco V., Pulakat L., Ferrario C.M., Parrish A., Sowers J.R. Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin. Am. J. Nephrol. 2011, 34:115-125.
36. Wolf G. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int. 2006, 70:1914-1919.
37. Yadav A., Vallabu S., Kumar D., Ding G., Charney D.N., Chander P.N., Singhal P.C. HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation. Am. J. Physiol. Renal Physiol. 2010, 298:F734-F744.
38. Yoshida T., Tabony A.M., Galvez S., Mitch W.E., Higashi Y., Sukhanov S., Delafontaine P. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia. Int. J. Biochem. Cell Biol. 2013, 45:2322-2332.